A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery

被引：0
|
作者：
R. C. G. Gallandat Huet
A. W. Siemons
D. Baus
W. T. van Rooyen-Butijn
J. A. M. Haagenaars
W. van Oeveren
F. Bepperling
机构：
[1] University Hospital Groningen,Department of Biomedical Engineering
[2] Hospital De Weezenlanden,Department of Thoracic Anesthesiology and Intensive Care
[3] Fresenius Kabi Deutschland GmbH,Fluid Therapy Division
[4] University Hospital Groningen,Department of Anesthesiology
来源：
Canadian Journal of Anesthesia | 2000年 / 47卷 / 12期
关键词：
Pulmonary Capillary Wedge Pressure; Hydroxyethyl Starch; Clin Drug Invest; Colloid Osmotic Pressure; Hetastarch;
D O I：
10.1007/BF03019870
中图分类号：
学科分类号：
摘要：
Purpose: To compare the new hydroxyethyl starch HES 130/0.4 (Voluven®) and the standard HES 200/0.5 (pentastarch) regarding effectiveness for plasma volume substitution and safety of large volumes in heart surgery.
引用
收藏
页码：1207 / 1215
页数：8
相关论文
共 50 条
  • [31] Comparison of the effect of 6% hydroxyethyl starch and gelatine on cardiac and stroke volume index: a randomized, controlled trial after cardiac surgery
    Schramko, Alexey A.
    Suojaranta-Ylinen, Raili T.
    Kuitunen, Anne H.
    Raivio, Peter M.
    Kukkonen, Sinikka I.
    Niemi, Tomi T.
    PERFUSION-UK, 2010, 25 (05): : 283 - 291
  • [32] Hydroxyethyl Starch vs Saline for Volume Expansion After Abdominal Surgery
    De Backer, Daniel
    Michiels, Gregoire
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02): : 200 - 200
  • [33] Perioperative red cell, plasma, and blood volume change in patients undergoing cardiac surgery
    Slight, RD
    Bappu, NJ
    Nzewi, OC
    McClelland, DBL
    Mankad, PS
    TRANSFUSION, 2006, 46 (03) : 392 - 397
  • [34] Voluven®, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5
    Langeron, O
    Doelberg, M
    Ang, ET
    Bonnet, F
    Capdevila, X
    Coriat, P
    ANESTHESIA AND ANALGESIA, 2001, 92 (04): : 855 - 862
  • [35] Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend (R)) with low molecular weight hydroxyethyl starch (Voluven (R)) at a large medical center
    Bartz, Raquel R.
    White, William D.
    Gan, Tong J.
    PERIOPERATIVE MEDICINE, 2015, 4
  • [36] Hydroxyethyl starch-induced bleeding after cardiac surgery reply
    Madger, Sheldon A.
    CRITICAL CARE MEDICINE, 2011, 39 (05) : 1240 - 1241
  • [37] Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery
    Niemi, TT
    Suojaranta-Ylinen, RT
    Kukkonen, SI
    Kuitunen, AH
    ANESTHESIA AND ANALGESIA, 2006, 102 (04): : 998 - 1006
  • [38] Renal impairment in cardiac surgery patients receiving hydroxyethyl starch - Reply
    Boldt, J
    INTENSIVE CARE MEDICINE, 2004, 30 (03) : 521 - 521
  • [39] CHARACTERIZATION OF HYDROXYETHYL STARCH BY POLYMER ANALYSIS FOR USE AS A PLASMA-VOLUME EXPANDER
    KULICKE, WM
    ROESSNER, D
    KULL, W
    STARCH-STARKE, 1993, 45 (12): : 445 - 450
  • [40] STUDIES ON HYDROXYETHYL STARCH .1. REVIEW OF CHEMISTRY OF HYDROXYETHYL STARCH, WITH REFERENCE TO ITS USE AS A BLOOD-PLASMA VOLUME EXPANDER
    BANKS, W
    GREENWOOD, CT
    MUIR, DD
    STARKE, 1972, 24 (06): : 181 - +
12345